
Entegris, Inc. develops, manufactures, and supplies microcontamination control products, specialty chemicals, and advanced materials handling solutions in North America, Taiwan, China, South Korea, Japan, Europe, and Southeast Asia. It operates in three segments: Specialty Chemicals and Engineered Materials (SCEM); Microcontamination Control (MC); and Advanced Materials Handling (AMH). The SCEM segment offers high-performance and high-purity process chemistries, gases, and materials, as well as delivery systems to support semiconductor and other advanced manufacturing processes. The MC segment provides solutions to filter and purify critical liquid chemistries and gases used in semiconductor manufacturing processes and other high-technology industries. The AMH segment develops solutions to monitor, protect, transport, and deliver critical liquid chemistries, wafers, and other substrates for application in the semiconductor, life sciences, and other high-technology industries. The company's customers include logic and memory semiconductor device manufacturers, semiconductor equipment makers, gas and chemical manufacturing companies, and wafer grower companies; and flat panel display equipment makers, panel manufacturers, and manufacturers of hard disk drive components and devices, as well as their related ecosystems. It also serves manufacturers and suppliers in the solar industries, electrical discharge machining customers, glass and glass container manufacturers, aerospace manufacturers, and manufacturers of biomedical implantation devices. Entegris, Inc. was founded in 1966 and is headquartered in Billerica, Massachusetts.
Entegris (ENTG) gains S&P MidCap 400 inclusion and reports strong Q4 2024 earnings, positioning it for growth in HPC, advanced packaging, and memory markets.
Entegris (ENTG) joins the S&P MidCap 400, reports strong Q4 2024 earnings, and benefits from CHIPS Act funding. A comprehensive analysis of ENTG's future outlook and market trends.
Entegris (ENTG) Q4 2024 earnings exceeded expectations, fueled by CHIPS Act funding and strategic market positioning in the semiconductor industry. A detailed analysis follows.
Entegris (ENTG) Q4 2024 earnings beat expectations, fueled by CHIPS Act funding and strong market positioning. A competitive analysis with MKS Instruments reveals key insights.
Entegris (ENTG) reported strong Q4 2024 earnings, exceeding expectations and securing $77 million in CHIPS Act funding. The company is well-positioned for future growth.
Entegris (ENTG) reported strong Q4 2024 earnings, exceeding expectations and demonstrating market outperformance, boosted by CHIPS Act funding. A detailed analysis follows.
Entegris (ENTG) Q4 2024 earnings exceeded expectations amid strong sector trends and CHIPS Act funding, setting stage for growth. Read the full analysis.